They showed that amyloid-beta-induced oxidative stress determines a neurovascular dysfunction through TRPM2 overactivation, suggesting that TRPM2 inhibition could be a therapeutic target for this neurodegenerative disease (62). The gene discussed is TRPM2; the disease is neurodegenerative disease.